Richard Terry

CEO, CTO, Founder

Before founding Harton, Terry was the CEO and CTO of ReadCoor, the leading commercial spatial biology platform. In 2016 and 2020, ReadCoor was nominated for NEVC Startup of the Year and NEVC Deal of the Year, respectively. In 2020, he successfully led the acquisition of ReadCoor by 10x Genomics for $350 million.

Prior to ReadCoor, Terry was the founding Lead Senior Staff Scientist at Harvard’s Wyss Institute for Biologically Inspired Engineering, where he transformed the Synthetic Biology Platform into the globally recognized Translational Synthetic Biology Group. His leadership drove groundbreaking innovations in sequencing, gene synthesis,

and gene editing, including Next-Gen Sequencing, Nanopore Sequencing, Spatial Sequencing, SeqTag, Ultra-Long DNA, Enzymatic DNA Synthesis, DNA Data Storage, programmable DNA nanotherapeutics, and CRISPR, TALEN, and Zinc Finger gene editing technologies.

Before joining the Wyss Institute and Harvard Medical School, Terry developed implantable vestibular nerve stimulators at Massachusetts Eye and Ear. Earlier in his career, as a Senior Project Manager at CERN, he oversaw the development of an optical subsystem of the Large Hadron Collider, enabling the discovery of the Higgs boson.

In recognition of his entrepreneurial achievements, Terry was named one of Goldman Sachs 100 Most Intriguing Entrepreneurs of 2020. He holds a Master of Science in Aerospace Engineering from Boston University, as well as multiple patents and publications across numerous scientific fields.